A piezoelectric micropump from Fraunhofer EMFT with dimensions of 3 x 5,3 mm.
Approximately 10% of the Western population will need to have an angioplasty surgery at some point due to an arrhythmia or for a heart valve replacement. These minimally invasive heart interventions are supported by a variety of intelligent imaging and sensor catheters that act like "eyes and ears" at the point of intervention. Researchers at Fraunhofer EMFT have developed a micropump implemented at the facility further so that it can be integrated into such "smart" cardiac catheters in the future. The pump could be used to transport stem cells into damaged heart tissue so that it regenerates.
more info